Differences in the Formation of Normal T Lymphocyte Colonies by Peripheral Blood Cells from Patients with Chronic Lymphocytic Leukemia and Hodgkin's Disease

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1979 Dec 1

PMID 317033

Citations 4

Authors

D Douer

L Sachs

Affiliations

Soon will be listed here.

Citing Articles

Human T-lymphocyte colonies: generation of colonies in different lymphocyte subpopulations.

Klein B, Caraux J, THIERRY C, Gauci L, Causse A, Serrou B Immunology. 1981; 43(1):39-45.

PMID: 6972905 PMC: 1555187.

Identification and partial purification of human T lymphocyte colony-enhancing factor (LCEF), distinct from T cell-growth factor.

Werber M, Daphna D, Goldman J, Joseph D, Radnay J, Rozenszajn L Immunology. 1983; 50(2):261-8.

PMID: 6604693 PMC: 1454340.

Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.

Werber M, Goldman J, Radnay J, Klein S, Rozenszajn L Immunology. 1985; 56(2):285-93.

PMID: 3876981 PMC: 1453699.

Normal natural killer cell activity in Hodgkin's disease patients in remission.

Douer D, SHAKED N, Ramot B Clin Exp Immunol. 1987; 69(3):660-7.

PMID: 3665188 PMC: 1542390.

References

Ginsburg H, Sachs L . FORMATION OF PURE SUSPENSIONS OF MAST CELLS IN TISSUE CULTURE BY DIFFERENTIATION OF LYMPHOID CELLS FROM THE MOUSE THYMUS. J Natl Cancer Inst. 1963; 31:1-39. View

KELLY W, LAMB D, VARCO R, GOOD R . An investigation of Hodgkin's disease with respect to the problem of homotransplantation. Ann N Y Acad Sci. 1960; 87:187-202. DOI: 10.1111/j.1749-6632.1960.tb23192.x. View

Goodwin J, Messner R, Bankhurst A, Peake G, Saiki J, Williams Jr R . Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977; 297(18):963-8. DOI: 10.1056/NEJM197711032971802. View

Smith S, Sachs L . Difference in the cell proliferation and colony-forming ability of normal human T lymphocytes. Clin Exp Immunol. 1979; 37(2):348-51. PMC: 1537814. View

Douer D, Sachs L . Production of human T cell colony-inducing activity (TCI) by malignant cells from patients with lymphocytic and myeloid leukemia. J Immunol. 1979; 122(6):2473-7. View

Gerassi E, Sachs L . Regulation of human T cell colonies by an inducing activity (TCI) produced by normal human and malignant mouse cells. J Immunol. 1978; 121(6):2547-53. View

Sachs L . Control of cloning of normal human T lymphocytes by transferrin, albumin and different lectins. Clin Exp Immunol. 1978; 33(3):495-8. PMC: 1537431. View

Sachs L . Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature. 1978; 274(5671):535-9. DOI: 10.1038/274535a0. View

Gerassi E, Sachs L . Regulation of the induction of colonies in vitro by normal human lymphocytes. Proc Natl Acad Sci U S A. 1976; 73(12):4546-50. PMC: 431536. DOI: 10.1073/pnas.73.12.4546. View

10.

Bradley T, Metcalf D . The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966; 44(3):287-99. DOI: 10.1038/icb.1966.28. View

11.

Winkelstein A, Mikulla J, Sartiano G, Ellis L . Cellular immunity in Hodgkin's disease: comparison of cutaneous reactivity and lymphoproliferative responses tp phytohemagglutinin. Cancer. 1974; 34(3):549-53. DOI: 10.1002/1097-0142(197409)34:3<549::aid-cncr2820340312>3.0.co;2-x. View

12.

Levy R, Kaplan H . Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974; 290(4):181-6. DOI: 10.1056/NEJM197401242900402. View

13.

Corder M, Young R, Brown R, DEVITA V . Phytohemagglutinin-induced lymphocyte transformation: the relationship to prognosis of Hodgkin's disease. Blood. 1972; 39(5):595-601. View

14.

Devita Jr V, SERPICK A, Carbone P . Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970; 73(6):881-95. DOI: 10.7326/0003-4819-73-6-881. View

15.

Aisenberg A, BLOCH K . Immunoglobulins on the surface of neoplastic lymphocytes. N Engl J Med. 1972; 287(6):272-6. DOI: 10.1056/NEJM197208102870603. View

16.

Eltringham J, Kaplan H . Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973; 36:107-15. View

17.

Wybran J, Chantler S, Fudenberg H . Isolation of normal T cells in chronic lymphatic leukaemia. Lancet. 1973; 1(7795):126-9. DOI: 10.1016/s0140-6736(73)90196-7. View

18.

Salsano F, Froland S, Natvig J, Michaelsen T . Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells. Scand J Immunol. 1974; 3(6):841-6. DOI: 10.1111/j.1365-3083.1974.tb01321.x. View

19.

Bobrove A, Fuks Z, Strober S, Kaplan H . Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975; 36(1):169-79. DOI: 10.1002/1097-0142(197507)36:1<169::aid-cncr2820360115>3.0.co;2-z. View

20.

Jondal M, Wigzell H, Aiuti F . Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev. 1973; 16:163-95. DOI: 10.1111/j.1600-065x.1973.tb00120.x. View